Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Labs, Test Makers To Finance Committee: Say "No" To Medicare Co-Pay

This article was originally published in The Gray Sheet

Executive Summary

Clinical laboratory stakeholders are trying to prevent a 20% Medicare lab co-payment provision from making it into the Senate Finance Committee's highly anticipated health care reform package

You may also be interested in...



Lab, Imaging Industries Fear Super Committee Cuts

Clinical laboratory and imaging industry groups fear that their industries could take a hit during the deficit-reducing “super committee” meetings scheduled for this November.

Lab, Imaging Industries Fear Super Committee Cuts

Clinical laboratory and imaging industry groups fear that their industries could take a hit during the deficit-reducing “super committee” meetings scheduled for this November.

AdvaMedDx Steps Into Public Sphere: Director Details Diagnostics Priorities

The recently established diagnostics arm of AdvaMed had what its executive director called a coming out party last week.

Topics

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel